5AFV
Pharmacophore-based virtual screening to discover new active compounds for human choline kinase alpha1.
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | DIAMOND BEAMLINE I04-1 |
Synchrotron site | Diamond |
Beamline | I04-1 |
Temperature [K] | 100 |
Detector technology | PIXEL |
Detector | DECTRIS PILATUS 6M-F |
Spacegroup name | P 21 21 21 |
Unit cell lengths | 56.129, 120.180, 132.393 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 132.390 - 2.250 |
R-factor | 0.22548 |
Rwork | 0.224 |
R-free | 0.26745 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 3g15 |
RMSD bond length | 0.013 |
RMSD bond angle | 1.544 |
Data scaling software | SCALEPACK |
Phasing software | MOLREP |
Refinement software | REFMAC (5.5.0110) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 20.000 | 2.370 |
High resolution limit [Å] | 2.250 | 2.250 |
Rmerge | 0.060 | 0.670 |
Number of reflections | 43397 | |
<I/σ(I)> | 34.8 | 5 |
Completeness [%] | 99.9 | 99.4 |
Redundancy | 23.2 | 14 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | 8.5 | PH 8.5 |